Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial (Q34660831)
Jump to navigation
Jump to search
scientific article published in April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial |
scientific article published in April 2014 |
Statements
1 reference
Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial (English)
1 reference
Diederick E Grobbee
1 reference
A Michael Lincoff
1 reference
Jean-Claude Tardif
1 reference
Ruth Cannata
1 reference
Arlette Weichert
1 reference
Gregory G Schwartz
1 reference
Stephen J Nicholls
1 reference
Lars Rydén
1 reference
Klas Malmberg
1 reference
Hans Wedel
1 reference
Robert R Henry
1 reference
Anders Svensson
1 reference
Dietmar Volz
1 reference
AleCardio Investigators
1 reference
1 reference
Identifiers
1 reference